These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9465857)

  • 21. Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension.
    Gillis JC; Markham A
    Drugs; 1997 Dec; 54(6):885-902. PubMed ID: 9421695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Organ protection in hypertensive type 2 diabetic patients. Double chance with AT1 blockers].
    MMW Fortschr Med; 2000 Jan; 142(3):58-9. PubMed ID: 10726465
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of cigarette smoking with steady-state plasma concentration of irbesartan in male Chinese with hypertension.
    Zhang S; Liu P; Jiang S; Hong X; Xing H; Xu X
    Methods Find Exp Clin Pharmacol; 2005 Apr; 27(3):173-8. PubMed ID: 15834449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.
    Ruilope L
    J Hypertens Suppl; 1997 Dec; 15(7):S15-20. PubMed ID: 9532516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics and pharmacodynamics of irbesartan in heart failure.
    Kostis JB; Vachharajani NN; Hadjilambris OW; Kollia GD; Palmisano M; Marino MR
    J Clin Pharmacol; 2001 Sep; 41(9):935-42. PubMed ID: 11549097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin receptor antagonists.
    Goldsmith DJ
    Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma atrial natriuretic peptide in essential hypertension after treatment with irbesartan.
    Kotridis P; Kokkas B; Karamouzis M; Sakadamis G; Kanonidis I; Dadous G; Karantona C; Gouli O; Karadoumanis J; Papadopoulos PC; Papadopoulos CL
    Blood Press; 2002; 11(2):91-4. PubMed ID: 12035877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The medicine of the month. Losartan (Cozaar)].
    Scheen AJ
    Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiotensin receptor blockers in essential hypertension.
    Brown MJ
    Lancet; 1993 Dec; 342(8884):1374-5. PubMed ID: 7901674
    [No Abstract]   [Full Text] [Related]  

  • 30. [Irbesartan--current trends in the management of hypertension].
    Dtsch Med Wochenschr; 1998 Feb; 123(8 Suppl):1-4. PubMed ID: 9531920
    [No Abstract]   [Full Text] [Related]  

  • 31. Fimasartan, a novel angiotensin II receptor antagonist.
    Kim JH; Lee JH; Paik SH; Kim JH; Chi YH
    Arch Pharm Res; 2012 Jul; 35(7):1123-6. PubMed ID: 22864732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irbesartan: review of pharmacology and comparative properties.
    Adams MA; Trudeau L
    Can J Clin Pharmacol; 2000; 7(1):22-31. PubMed ID: 10822210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [EFFECTIVE data. New effectiveness dimensions in antihypertensive combination therapy].
    MMW Fortschr Med; 2011 Jan; 153(4):50. PubMed ID: 22165620
    [No Abstract]   [Full Text] [Related]  

  • 34. EC approves irbesartan for the treatment of diabetic renal disease.
    Cardiovasc J S Afr; 2002; 13(4):216-7. PubMed ID: 12402931
    [No Abstract]   [Full Text] [Related]  

  • 35. [Enalapril and irbesartan in treatment of patients with arterial hypertension].
    Tashchuk VK; Ilashchuk TO
    Lik Sprava; 2002; (3-4):114-6. PubMed ID: 12145874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irbesartan achieves consistent and effective use over 1 year.
    Cardiovasc J S Afr; 2001; 12(2):126. PubMed ID: 11474701
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of irbesartan--angiotensin II type I receptor inhibitor on oxidative metabolism of lipids in essential hypertension].
    Svishchenko IeP; Kotsiuruba AV; Mehed' OF; Bukhanevich OM; Radchenko VV; Hula NM
    Fiziol Zh (1994); 2002; 48(6):31-6. PubMed ID: 12577466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II Receptor Antagonists: Can they Go Beyond ACE Inhibitors? Proceedings of a satellite symposium to the 15th scientific meeting of the International Society of Hypertension. Melbourne, Australia, March 1994.
    Blood Press Suppl; 1994; 5():1-133. PubMed ID: 7889189
    [No Abstract]   [Full Text] [Related]  

  • 39. Candesartan for hypertension.
    Med Lett Drugs Ther; 1998 Nov; 40(1040):109-10. PubMed ID: 9844624
    [No Abstract]   [Full Text] [Related]  

  • 40. Fimasartan: A New Angiotensin Receptor Blocker.
    Lee HY; Oh BH
    Drugs; 2016 Jul; 76(10):1015-22. PubMed ID: 27272555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.